BridgeBio Pharma, Inc. (BBIO)
67.37
-0.24
(-0.35%)
USD |
NASDAQ |
Jun 08, 16:00
67.37
0.00 (0.00%)
After-Hours: 16:36
BridgeBio Pharma Total Liabilities (Quarterly) : 3.640B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 117.21B |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Ionis Pharmaceuticals, Inc. | 2.959B |
| BioMarin Pharmaceutical, Inc. | 2.379B |
| Cytokinetics, Inc. | 2.100B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.371B |
| Shareholders Equity (Quarterly) | -2.278B |
| Debt to Equity Ratio | -1.486 |
| Current Ratio | 1.520 |
| Net Debt Paydown Yield | -1.62% |